LATEST

Groups praise lawsuit against Walgreens, CVSPharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
FDA warns about contaminated drugs, dietary supplementsFDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.
DEA wants to slash opioid productionThe Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
Popular insulin meets target in real-world studyNovo Nordisk’s DEVOTE study reveals interesting findings.
FDA approves Bayer’s Bluetooth-enabled auto-injector for multiple sclerosisFDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients
FDA to drug maker: Pull opioid pain drugPotential public health consquences prompts FDA to request removal of opioid pain medication.
FDA approves EpiPen rivalAdamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.
Asthma biologic may reduce oral steroid useA new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
Investigational drug appears beneficial in preventing migrainesLilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.
Drugmaker recalls samples of antiplatelet drugAstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.

Poll

View Results